Greenphire Announces Results From 2022 Annual Market Trends Survey
Results reveal shift in clinical trial priorities; payment efficiencies emerge as leading concern for sponsors, CROs, and sites.
Greenphire announced results from its 2022 annual market trends survey which examined top challenges and opportunities for sponsors, CROs, and sites across the world. While survey respondents represented a variety of therapeutic areas, including cardiovascular, medical device, rare diseases, infectious diseases and oncology, responses across the board revealed payments as a central concern for all stakeholders.
Read more about the survey results
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
How the NIMBLE Study Supported Adherence With Quarterly Dosing of CemdisiranSeptember 18th 2025
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
